Nanoparticles and targeted drug delivery in cancer therapyBehdokht Bahrami, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi et al.|Immunology Letters|2017Cited by 507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancerAli Masjedi, Farhad Jadidi‐Niaragh, Vida Hashemi et al.|Biomedicine & Pharmacotherapy|2018Cited by 312
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancerMohammad Hossein Kazemi, Farhad Jadidi‐Niaragh, Sahar Raoofi Mohseni et al.|Journal of Cellular Physiology|2017Cited by 150
CD73 as a potential opportunity for cancer immunotherapyGhasem Ghalamfarsa, Farhad Jadidi‐Niaragh, Mohammad Hossein Kazemi et al.|Expert Opinion on Therapeutic Targets|2018Cited by 143
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancerVahid Karpisheh, Farhad Jadidi‐Niaragh, Afshin Nikkhoo et al.|Prostaglandins & Other Lipid Mediators|2019Cited by 126